| RLAY Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RLAY shares outstanding history going back to 7/16/2020:
Also see: RLAY Market Cap History RLAY YTD Return |
RLAY Shares Outstanding History — Relay Therapeutics Share Count Over Time
As of 5/1/2026 Relay Therapeutics has 191.59 million RLAY shares outstanding. Investors often track the RLAY shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RLAY share count trends over time, with 25 historical shares outstanding datapoints presented, dating back to 7/16/2020.
| RLAY Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||
RLAY Historical Shares Outstanding: +15.88% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| RLAY Stock Price Chart |
| About Relay Therapeutics Inc |
| Relay Therapeutics Inc. is a clinical-stage precision medicine company. Co. is focused on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. Co.'s Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Co.'s lead product candidates, such as RLY-2608, Lirafugratinib (RLY-4008), and Migoprotafib (GDC-1971). RLY-2608 is an allosteric, pan-mutant and isoform-selective phosphoinostide 3 kinase alphas (PI3K?), inhibitor. We show 25 historical shares outstanding datapoints in our coverage of RLAY's shares outstanding history. Understanding the changing numbers of RLAY shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RLAY versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RLAY by allowing them to research RLAY shares outstanding history as well as any other stock in our coverage universe. |
| RLAY Current Stock Quote |
Quotes delayed 20 minutes  Free RLAY Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| RLAY Share Performance |
| Shares Outstanding Peers |
| Relay Therapeutics (RLAY) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RLMD Shares Outstanding History RLYB Shares Outstanding History RMD Shares Outstanding History RMED Shares Outstanding History RMTI Shares Outstanding History RNA Shares Outstanding History RNAC Shares Outstanding History RNAZ Shares Outstanding History RNTX Shares Outstanding History RNXT Shares Outstanding History More Healthcare companies » |
RLAY Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
